AN1

Anagenics Limited

About AN1

Anagenics Limited (AN1, formerly Cellmid Limited) is an Australian life sciences accelerator for indication of multiple diseases. It operates mainly through its wholly owned subsidiaries that develop and market innovative novel therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company holds global intellectual properties relating to novel targets midkine and FGF5.

Buy Australian shares starting with AN1. Invest today with a CHESS-sponsored broker!

Sector

Consumer Staples

CEO

Mr Matthew Dudek

Industry

Personal Products

Website

cellmid.com.au

Market Capitalisation

$10M

Price-earnings ratio

-1.49

Dividend yield

0.00%

High today

$0.03

Low today

$0.03

Open price

$0.03

52-week high

$0.05

52-week low

$0.02

Announcements

AN1 FAQs

How much is one share of Anagenics Limited?

One share of Anagenics Limited is valued at $0.03.

What is the ticker symbol for Anagenics Limited?

The ticker symbol for Anagenics Limited is AN1.

How do I buy AN1 shares in Australia?

To buy AN1 stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in AN1

What is the 52-week high for Anagenics Limited stock?

The Anagenics Limited 52-week high stock price is $0.05.

What is the 52-week low for Anagenics Limited stock?

The Anagenics Limited 52-week low stock price is $0.02.

What is the market capitalisation of Anagenics Limited AN1?

As of 25/03/2023 Anagenics Limited has a market cap of $10M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.